By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Synosia Therapeutics 

601 Gateway Boulevard
Suite 1200
South San Francisco  California  94080  U.S.A.
Phone: 650-244-4850 Fax: 650-244-4874


SEARCH JOBS


Industry
Pharmaceutical






Company News
BioTie Therapies Corp. to Acquire CNS Therapeutics Firm Synosia Therapeutics in $121.5M All-Shares Deal 1/11/2011 8:43:32 AM
Synosia Therapeutics Presents Data from Clinical Trial of SYN-118 As A New Treatment For Parkinson's Disease 9/29/2010 9:52:51 AM
Synosia Therapeutics' SYN-115 Improves Motor and Non-Motor Function in Patients with Mild- to-Moderate Parkinson's Disease 4/14/2010 10:42:04 AM
Synosia Therapeutics' SYN-115 Improves Motor and Non-Motor Function in Patients with Mild- to-Moderate Parkinson's Disease 4/14/2010 6:31:16 AM
Synosia Therapeutics Announces Positive Interim Results for Potential First-in-Class Treatment for Parkinson's Disease 2/1/2010 10:52:59 AM
Synosia Therapeutics Announces Second Agreement with Roche (RHHBY) 3/10/2009 7:39:19 AM
Synosia Therapeutics Raises CHF32 Million in Series B Private Financing 1/7/2009 7:05:33 AM
Synosia Therapeutics Starts Phase II Efficacy Trial For Rufinamide 3/31/2008 7:37:26 AM
Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland 2/4/2008 7:51:51 AM
Synosia Therapeutics Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug 1/22/2008 8:12:44 AM
12
//-->